Intravenous/Subcutaneous Treprostinil; Oral Treprostinil
TDE-PH-402
Approved small_molecule completed
Quick answer
Intravenous/Subcutaneous Treprostinil; Oral Treprostinil for Pulmonary Arterial Hypertension is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Pulmonary Arterial Hypertension
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed